Cargando…

Efficacy and Safety of Maxing Xianchang Su in the Treatment of Functional Constipation: A Randomized Controlled Trial

BACKGROUND: Functional constipation (FC) is one of the prevalent gastrointestinal disorders that affect people of all ages. Long-term FC has significant effects on the quality of life of patients. Although commonly used drugs have reliable short-term effects, they are easily addictive and have side...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mi, Zhao, Lijuan, Ma, Li, Zhang, Wen, Huang, Hua, Wei, Jun, Sun, Jun, Lu, Fenying, Ji, Lijiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639258/
https://www.ncbi.nlm.nih.gov/pubmed/34868330
http://dx.doi.org/10.1155/2021/3685440
_version_ 1784609113158713344
author Li, Mi
Zhao, Lijuan
Ma, Li
Zhang, Wen
Huang, Hua
Wei, Jun
Sun, Jun
Lu, Fenying
Ji, Lijiang
author_facet Li, Mi
Zhao, Lijuan
Ma, Li
Zhang, Wen
Huang, Hua
Wei, Jun
Sun, Jun
Lu, Fenying
Ji, Lijiang
author_sort Li, Mi
collection PubMed
description BACKGROUND: Functional constipation (FC) is one of the prevalent gastrointestinal disorders that affect people of all ages. Long-term FC has significant effects on the quality of life of patients. Although commonly used drugs have reliable short-term effects, they are easily addictive and have side effects. Therefore, pursuing a convenient drug-food homogenous program is critical for FC patients. Maxing Xianchang Su is a functional food based on traditional Chinese medicine. To investigate the efficacy and safety of Maxing Xianchang Su in FC treatment, we conducted a randomized controlled trial. METHODS: We carried out a prospective multicenter randomized parallel controlled study in three hospitals in Jiangsu Province, China, from January 2020 to March 2021, which included 206 FC patients. All patients were arbitrarily assigned into a treatment group and a control group at a ratio of 1 : 1; 103 cases in each group. The treatment group was given oral Maxing Xianchang Su, whereas the control group was treated with lactulose oral solution. The course of treatment was two weeks. The two groups of patients were evaluated after six weeks for symptom improvement before and after taking the drug. Furthermore, the safety of Maxing Xianchang Su was assessed. RESULTS: Both groups of patients successfully completed the study without shedding cases. The effective rates of the treatment group and control group after two weeks were 90.6% and 67.0%, respectively. The treatment group had a better curative effect than the control group (P < 0.05). The symptom score of the two groups improved compared with that before the treatment. The difference between the two groups was statistically significant (P < 0.05). During the treatment process, neither group experienced abnormal changes in blood lipid, blood glucose, routine hematuria, or liver and kidney functions. There were no adverse reactions in both groups. CONCLUSION: Maxing Xianchang Su has a positive effect on FC treatment with reliable mid-term effect and a high level of safety.
format Online
Article
Text
id pubmed-8639258
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-86392582021-12-03 Efficacy and Safety of Maxing Xianchang Su in the Treatment of Functional Constipation: A Randomized Controlled Trial Li, Mi Zhao, Lijuan Ma, Li Zhang, Wen Huang, Hua Wei, Jun Sun, Jun Lu, Fenying Ji, Lijiang Evid Based Complement Alternat Med Research Article BACKGROUND: Functional constipation (FC) is one of the prevalent gastrointestinal disorders that affect people of all ages. Long-term FC has significant effects on the quality of life of patients. Although commonly used drugs have reliable short-term effects, they are easily addictive and have side effects. Therefore, pursuing a convenient drug-food homogenous program is critical for FC patients. Maxing Xianchang Su is a functional food based on traditional Chinese medicine. To investigate the efficacy and safety of Maxing Xianchang Su in FC treatment, we conducted a randomized controlled trial. METHODS: We carried out a prospective multicenter randomized parallel controlled study in three hospitals in Jiangsu Province, China, from January 2020 to March 2021, which included 206 FC patients. All patients were arbitrarily assigned into a treatment group and a control group at a ratio of 1 : 1; 103 cases in each group. The treatment group was given oral Maxing Xianchang Su, whereas the control group was treated with lactulose oral solution. The course of treatment was two weeks. The two groups of patients were evaluated after six weeks for symptom improvement before and after taking the drug. Furthermore, the safety of Maxing Xianchang Su was assessed. RESULTS: Both groups of patients successfully completed the study without shedding cases. The effective rates of the treatment group and control group after two weeks were 90.6% and 67.0%, respectively. The treatment group had a better curative effect than the control group (P < 0.05). The symptom score of the two groups improved compared with that before the treatment. The difference between the two groups was statistically significant (P < 0.05). During the treatment process, neither group experienced abnormal changes in blood lipid, blood glucose, routine hematuria, or liver and kidney functions. There were no adverse reactions in both groups. CONCLUSION: Maxing Xianchang Su has a positive effect on FC treatment with reliable mid-term effect and a high level of safety. Hindawi 2021-11-25 /pmc/articles/PMC8639258/ /pubmed/34868330 http://dx.doi.org/10.1155/2021/3685440 Text en Copyright © 2021 Mi Li et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Li, Mi
Zhao, Lijuan
Ma, Li
Zhang, Wen
Huang, Hua
Wei, Jun
Sun, Jun
Lu, Fenying
Ji, Lijiang
Efficacy and Safety of Maxing Xianchang Su in the Treatment of Functional Constipation: A Randomized Controlled Trial
title Efficacy and Safety of Maxing Xianchang Su in the Treatment of Functional Constipation: A Randomized Controlled Trial
title_full Efficacy and Safety of Maxing Xianchang Su in the Treatment of Functional Constipation: A Randomized Controlled Trial
title_fullStr Efficacy and Safety of Maxing Xianchang Su in the Treatment of Functional Constipation: A Randomized Controlled Trial
title_full_unstemmed Efficacy and Safety of Maxing Xianchang Su in the Treatment of Functional Constipation: A Randomized Controlled Trial
title_short Efficacy and Safety of Maxing Xianchang Su in the Treatment of Functional Constipation: A Randomized Controlled Trial
title_sort efficacy and safety of maxing xianchang su in the treatment of functional constipation: a randomized controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639258/
https://www.ncbi.nlm.nih.gov/pubmed/34868330
http://dx.doi.org/10.1155/2021/3685440
work_keys_str_mv AT limi efficacyandsafetyofmaxingxianchangsuinthetreatmentoffunctionalconstipationarandomizedcontrolledtrial
AT zhaolijuan efficacyandsafetyofmaxingxianchangsuinthetreatmentoffunctionalconstipationarandomizedcontrolledtrial
AT mali efficacyandsafetyofmaxingxianchangsuinthetreatmentoffunctionalconstipationarandomizedcontrolledtrial
AT zhangwen efficacyandsafetyofmaxingxianchangsuinthetreatmentoffunctionalconstipationarandomizedcontrolledtrial
AT huanghua efficacyandsafetyofmaxingxianchangsuinthetreatmentoffunctionalconstipationarandomizedcontrolledtrial
AT weijun efficacyandsafetyofmaxingxianchangsuinthetreatmentoffunctionalconstipationarandomizedcontrolledtrial
AT sunjun efficacyandsafetyofmaxingxianchangsuinthetreatmentoffunctionalconstipationarandomizedcontrolledtrial
AT lufenying efficacyandsafetyofmaxingxianchangsuinthetreatmentoffunctionalconstipationarandomizedcontrolledtrial
AT jilijiang efficacyandsafetyofmaxingxianchangsuinthetreatmentoffunctionalconstipationarandomizedcontrolledtrial